Australian skincare developer Ego Pharmaceuticals has appointed independent media agency Half Dome to drive its entire media and digital performance, including the company’s ongoing digital transformation.
Following a competitive pitch, Half Dome will be responsible for delivering media strategy, planning and implementation across all of Ego’s offline and digital channels, while also supporting the business through its digital transformation across eight major brands, including sensitive skincare range QV, Sunsense sunscreens, and Aqium hand sanitiser.
L-R Ashwin Govender, group business director, Half Dome, Tenille Taylor, marketing manager ANZ, Ego Pharmaceuticals and Tom Frazer, managing partner and general manager, Half Dome.
Ego Pharmaceuticals is an Australian-owned family business, which has led the development, manufacture, and marketing of innovative skincare products for more than 65 years. The business is a national leader in creating skincare backed by science, for people who want healthy skin. It is home to some of Australia’s best-known dermatological skincare brands, including Pinetarsol, Dermaid, and Moov.
Ego Pharmaceuticals ANZ marketing manager, Tenille Taylor, said: “Half Dome’s pitch and presentation were a clear stand-out. Cultural fit is important to us, and our teams just clicked straight away. We are thrilled to be working with Half Dome to find new and exciting ways to connect with our customers. From Half Dome’s proposal, we got a clear picture of how the agency will help us advance our digital maturity across both our established brands and our new, fast-growing brands like etchðos and Azclear.”
Half Dome group business director, Ashwin Govender, said: “We are delighted to be working with Ego. From the outset, there were synergies in our core values – we both have clear, ambitious goals for continued, sustainable growth, and we felt an instant connection with the Ego team. We can’t wait to push the boundaries and deliver success for Ego over many years to come.”
The Ego Pharmaceuticals’ appointment follows Half Dome’s recent client wins, including Australian pet company Petspiration Group, and craft drinks company Mighty Craft, as well as the acquisition of traditional media agency Consumedia in late 2021, shifting the agency from being digital-only to digital-first.
The Ego Pharmaceuticals’ appointment is effective July 1 2022.
